Straight from the Desk

Syz the moment

Live feeds, charts, breaking stories, all day long.

4 Sep 2023

95% of investors underperform the market

Source: JP Morgan

25 Aug 2023

After the outstanding Nvidia figures and outlook, analysts have raised the avg price target for the chip giant from $520 to $620

Source: HolgerZ, Bloomberg

25 Aug 2023

The median year since 1928 has experienced a 13% intra-year drawdown in the S&P 500, making 2023 relatively mild by comparison

The 7.8% pullback in February-March is the largest thus far. Soruce: Charlie Bilello

23 Aug 2023

Eli Lilly stock hit a new record high yesterday as the company continues to record a surge in sales for its buzzy diabetes drug Mounjaro

Sales of Mounjaro, which has also gained popularity for weight loss, came in at $979.7 million for the second quarter, up from $16 million a year earlier when it was introduced (2Q results were publichsed 2 weeks ago). That helped the drug company post higher-than-expected sales for the second quarter. Novo Nordisk is also surfing on the strong demand for a similar weight loss blockbuster

14 Aug 2023

The best performance stocks in the S&P 500 this year...

Source: Charlie Bilello

14 Aug 2023

Crude Oil cannot be stopped! It just had its 7th consecutive green week, its longest winning streak since February 2022

Source: Barchart

7 Aug 2023

EM returns over past 5-10yrs have been lackluster, w/most EM equities returning low-to-mid single digits

Over longer-term, returns range from extraordinary (India: 1000%) to respectable (Indonesia: 469%) despite volatility & some prolonged periods of choppy trading, BofA has calculated. All EMs have outperformed China's 22% total return. Source: HolgerZ, BofA, Bloomberg

7 Aug 2023

Should you do the opposite of what Wall Street strategists say? Data over the last 3.5 years suggests that strategists underperform the S&P 500

Source: Barchart, Bloomberg

Thinking out loud

Sign up for our weekly email highlighting the most popular posts.

Follow us

Thinking out loud

Investing with intelligence

Our latest research, commentary and market outlooks